| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/01/2006 | US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116389 Antibacterial oxazolidinones |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116386 Oxazolidinones as antibacterial agents |
| 06/01/2006 | US20060116376 Therapy of central nervous disorders and conditions including attention deficit hyperactivity disorder, neuropathic pain, urinary incontinence, anxiety, depression, and schizophrenia and fibromyalgia |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060114552 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom |
| 06/01/2006 | US20060113530 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 06/01/2006 | CA2589250A1 Diazepine oxazolidinones as antibacterial agents |
| 06/01/2006 | CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/01/2006 | CA2587860A1 Chroman compounds |
| 06/01/2006 | CA2587853A1 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | CA2587360A1 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | CA2587256A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | CA2587178A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders |
| 06/01/2006 | CA2586972A1 Cycloalkyl piperidine tachykinin receptor antagonists |
| 05/31/2006 | EP1661892A1 Condensed ring compound and use thereof |
| 05/31/2006 | EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660492A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660491A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660490A1 Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 05/31/2006 | EP1660489A1 Intermediate products for producing oxazolidinone-quinolone hybrids |
| 05/31/2006 | EP1660488A1 Novel antimicrobial aryloxazolidinone compounds |
| 05/31/2006 | EP1660487A1 Pyrrole compositions useful as inhibitors of c-met |
| 05/31/2006 | EP1660486A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 05/31/2006 | EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660465A2 Process for the synthesis of biaryl oxazolidinones |
| 05/31/2006 | EP1660464A1 Caspase inhibitors containing isoxazoline ring |
| 05/31/2006 | EP1660460A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660090A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1392295B1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
| 05/31/2006 | EP1390356B1 Arylisoxazoline derivatives, method for production and use thereof as pesticides |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1780830A Aniline derivatives, their manufacture and use as pharmaceutical agents |
| 05/31/2006 | CN1780823A Heteroaromatic pentacyclic compound and medicinal use thereof |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/30/2006 | US7053222 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053138 For thermoplastic, thermosetting resin; using phosphinic compound |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/30/2006 | US7053095 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | CA2398159C Sulphonylaminocarbonyltriazolinones having substitutents bonded via oxygen |
| 05/30/2006 | CA2391659C Crystal forms of azithromycin |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/26/2006 | WO2006055964A2 Zolmitriptan crystal forms |
| 05/26/2006 | WO2006055561A2 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 05/26/2006 | WO2006055359A1 Mixed antibiotic codrugs |
| 05/26/2006 | WO2006054912A1 Aryl(hetaryl)-3-aminomethyl-quinilone-2 derivatives in the form of no-synthetase i and cyclooxygenase-2 nhibitors, methods for the production thereof and compositions based thereon |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | WO2006053429A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| 05/26/2006 | WO2006036743A3 Halocombstatins and methods of synthesis thereof |
| 05/26/2006 | WO2006016237A3 Heterocyclic derivatives as anti-inflammatory agents |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2587533A1 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/26/2006 | CA2580150A1 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111370 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 5-(3-(3-trifluoromethoxyphenyl)phenyl)-2,5-dimethyl-1,2,4-oxadiazinan-3-imine, for example |
| 05/25/2006 | US20060111364 Reversible inhibitors of cysteine proteases S, K, F, L and B; N-[2-(Benzylamino)pyrimidin-4-yl]-N-(cyanomethyl)-L-phenylalaninamide |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/25/2006 | US20060111355 6-({(2S)-4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]-2-methylpiperazin-1-yl}methyl)quinoxaline; orally bioavailable; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, primary hirsutism, or LH surge |
| 05/25/2006 | US20060111351 Aryl sulfonamides |
| 05/25/2006 | US20060111350 Solid forms of linezolid and processes for preparation thereof |